{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T06:48:21Z","timestamp":1775803701100,"version":"3.50.1"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T00:00:00Z","timestamp":1659657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Automated tools for characterising dementia risk have the potential to aid in the diagnosis, prognosis, and treatment of Alzheimer\u2019s disease (AD). Here, we examined a novel machine learning-based brain atrophy marker, the AD-resemblance atrophy index (AD-RAI), to assess its test-retest reliability and further validate its use in disease classification and prediction.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Age- and sex-matched 44 probable AD (Age: 69.13 \u00b1 7.13; MMSE: 27\u201330) and 22 non-demented control (Age: 69.38 \u00b1 7.21; MMSE: 27\u201330) participants were obtained from the Minimal Interval Resonance Imaging in Alzheimer\u2019s Disease (MIRIAD) dataset. Serial T1-weighted images (<jats:italic>n<\/jats:italic> = 678) from up to nine time points over a 2-year period, including 179 pairs of back-to-back scans acquired on same participants on the same day and 40 pairs of scans acquired at 2-week intervals were included. All images were automatically processed with AccuBrain<jats:sup>\u00ae<\/jats:sup> to calculate the AD-RAI. Its same-day repeatability and 2-week reproducibility were first assessed. The discriminative performance of AD-RAI was evaluated using the receiver operating characteristic curve, where DeLong\u2019s test was used to evaluate its performance against quantitative medial temporal lobe atrophy (QMTA) and hippocampal volume adjusted by intracranial volume (ICV)-proportions and ICV-residuals methods, respectively (HVR and HRV). Linear mixed-effects modelling was used to investigate longitudinal trajectories of AD-RAI and baseline AD-RAI prediction of cognitive decline. Finally, the longitudinal associations between AD-RAI and MMSE scores were assessed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>AD-RAI had excellent same-day repeatability and excellent 2-week reproducibility. AD-RAI\u2019s AUC (99.8%; 95%CI = [99.3%, 100%]) was equivalent to that of QMTA (96.8%; 95%CI = [92.9%, 100%]), and better than that of HVR (86.8%; 95%CI = [78.2%, 95.4%]) or HRV (90.3%; 95%CI = [83.0%, 97.6%]). While baseline AD-RAI was significantly higher in the AD group, it did not show detectable changes over 2 years. Baseline AD-RAI was negatively associated with MMSE scores and the rate of the change in MMSE scores over time. A negative longitudinal association was also found between AD-RAI values and the MMSE scores among AD patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The AD-RAI represents a potential biomarker that may support AD diagnosis and be used to predict the rate of future cognitive decline in AD patients.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnagi.2022.932125","type":"journal-article","created":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T11:14:35Z","timestamp":1659698075000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Validation of the Alzheimer\u2019s disease-resemblance atrophy index in classifying and predicting progression in Alzheimer\u2019s disease"],"prefix":"10.3389","volume":"14","author":[{"given":"Qiling","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yishan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian B.","family":"Malone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent C. T.","family":"Mok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James H.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melis","family":"Anat\u00fcrk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1177\/0284185118795327","article-title":"Standardization of hippocampus volumetry using automated brain structure volumetry tool for an initial Alzheimer\u2019s disease imaging biomarker.","volume":"60","author":"Abrigo","year":"2019","journal-title":"Acta Radiol."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2017.00456","article-title":"Repeated measures correlation.","volume":"8","author":"Bakdash","year":"2017","journal-title":"Front. Psychol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/uog.5256","article-title":"Reliability, repeatability and reproducibility: analysis of measurement errors in continuous variables.","volume":"31","author":"Bartlett","year":"2008","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2059799116672875","article-title":"Test-retest: agreement or reliability?","volume":"9","author":"Berchtold","year":"2016","journal-title":"Methodol. Innov."},{"key":"B5","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing agreement between two methods of clinical measurement.","volume":"1","author":"Bland","year":"1986","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.neuroimage.2018.08.040","article-title":"Using high-dimensional machine learning methods to estimate an anatomical risk factor for Alzheimer\u2019s disease across imaging databases.","volume":"183","author":"Casanova","year":"2018","journal-title":"Neuroimage"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1016\/j.neurobiolaging.2013.02.002","article-title":"Measurements of medial temporal lobe atrophy for prediction of Alzheimer\u2019s disease in subjects with mild cognitive impairment.","volume":"34","author":"Clerx","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1093\/brain\/awp091","article-title":"Longitudinal progression of Alzheimer\u2019s-like patterns of atrophy in normal older adults: the SPARE-AD index.","volume":"132","author":"Davatzikos","year":"2009","journal-title":"Brain"},{"key":"B9","doi-asserted-by":"publisher","first-page":"253","DOI":"10.2217\/nmt.14.13","article-title":"Alzheimer\u2019s disease and vascular dementia: one potentially preventable and modifiable disease. Part I: pathology, diagnosis and screening.","volume":"4","author":"Davey","year":"2014","journal-title":"Neurodegener. Dis. Manag."},{"key":"B10","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"B11","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1093\/brain\/aww319","article-title":"Heterogeneity of neuroanatomical patterns in prodromal Alzheimer\u2019s disease: links to cognition, progression and biomarkers.","volume":"140","author":"Dong","year":"2017","journal-title":"Brain"},{"key":"B12","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer\u2019s disease: the IWG-2 criteria.","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S1474-4422(21)00066-1","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: recommendations of the International Working Group.","volume":"20","author":"Dubois","year":"2021","journal-title":"Lancet Neurol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1161\/CIRCULATIONAHA.107.714618","article-title":"A primer in longitudinal data analysis.","volume":"118","author":"Fitzmaurice","year":"2008","journal-title":"Circulation"},{"key":"B15","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician.","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1212\/WNL.52.8.1687","article-title":"Correlation between rates of brain atrophy and cognitive decline in AD.","volume":"52","author":"Fox","year":"1999","journal-title":"Neurology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nrneurol.2009.215","article-title":"The clinical use of structural MRI in Alzheimer disease.","volume":"6","author":"Frisoni","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101614","article-title":"Artificial intelligence in brain MRI analysis of Alzheimer\u2019s disease over the past 12 years: a systematic review.","volume":"77","author":"Frizzell","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"B19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","article-title":"The meaning and use of the area under a receiver operating characteristic (ROC) curve.","volume":"143","author":"Hanley","year":"1982","journal-title":"Radiology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.jalz.2011.04.007","article-title":"Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer\u2019s disease.","volume":"7","author":"Jack","year":"2011","journal-title":"Alzheimers Dement."},{"key":"B21","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease.","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement."},{"key":"B22","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jalz.2012.02.007","article-title":"Vascular disease and dementias: paradigm shifts to drive research in new directions.","volume":"9","author":"Kling","year":"2013","journal-title":"Alzheimers Dement."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease.","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","article-title":"A guideline of selecting and reporting intraclass correlation coefficients for reliability research.","volume":"15","author":"Koo","year":"2016","journal-title":"J. Chiropr. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1146\/annurev-pathmechdis-030421-112756","article-title":"Apolipoprotein E and Alzheimer\u2019s disease: findings, hypotheses, and potential mechanisms.","volume":"17","author":"Koutsodendris","year":"2022","journal-title":"Annu. Rev. Pathol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?","volume":"17","author":"Leng","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"13496","DOI":"10.18632\/aging.203082","article-title":"MRI-based Alzheimer\u2019s disease-resemblance atrophy index in the detection of preclinical and prodromal Alzheimer\u2019s disease.","volume":"13","author":"Liu","year":"2021","journal-title":"Aging"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009628.pub2","article-title":"Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer\u2019s disease in people with mild cognitive impairment.","volume":"3","author":"Lombardi","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1212\/WNL.0b013e318295d6cf","article-title":"Application of the national institute on aging-alzheimer\u2019s association AD criteria to ADNI.","volume":"80","author":"Lowe","year":"2013","journal-title":"Neurology"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101544","article-title":"Biomarkers used in Alzheimer\u2019s disease diagnosis, treatment, and prevention.","volume":"74","author":"Mahaman","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.859492","article-title":"AD resemblance atrophy index of brain magnetic resonance imaging in predicting the progression of mild cognitive impairment carrying apolipoprotein E-epsilon4 Allele.","volume":"14","author":"Mai","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.3233\/JAD-201033","article-title":"AD resemblance atrophy index as a diagnostic biomarker for Alzheimer\u2019s disease: a retrospective clinical and biological validation.","volume":"79","author":"Mai","year":"2021","journal-title":"J. Alzheimers Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.neuroimage.2012.12.044","article-title":"MIRIAD\u2013Public release of a multiple time point Alzheimer\u2019s MR imaging dataset.","volume":"70","author":"Malone","year":"2013","journal-title":"Neuroimage"},{"key":"B34","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1037\/1082-989X.1.1.30","article-title":"Forming inferences about some intraclass correlation coefficients.","volume":"1","author":"McGraw","year":"1996","journal-title":"Psychol. Methods"},{"key":"B35","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease.","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.neuroimage.2008.10.031","article-title":"Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: results from ADNI.","volume":"44","author":"Misra","year":"2009","journal-title":"Neuroimage"},{"key":"B37","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.pscychresns.2011.01.007","article-title":"Statistical adjustments for brain size in volumetric neuroimaging studies: some practical implications in methods.","volume":"193","author":"O\u2019Brien","year":"2011","journal-title":"Psychiatry Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.arr.2016.01.002","article-title":"Brain atrophy in Alzheimer\u2019s Disease and aging.","volume":"30","author":"Pini","year":"2016","journal-title":"Ageing Res. Rev."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2015.00238","article-title":"Marked effects of intracranial volume correction methods on sex differences in neuroanatomical structures: a HUNT MRI study.","volume":"9","author":"Pintzka","year":"2015","journal-title":"Front. Neurosci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1212\/WNL.0000000000004670","article-title":"Alzheimer disease brain atrophy subtypes are associated with cognition and rate of decline.","volume":"89","author":"Risacher","year":"2017","journal-title":"Neurology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer\u2019s disease.","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"B42","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S1474-4422(02)00002-9","article-title":"Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion.","volume":"1","author":"Scheltens","year":"2002","journal-title":"Lancet Neurol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/joim.12028","article-title":"An MRI-based index to measure the severity of Alzheimer\u2019s disease-like structural pattern in subjects with mild cognitive impairment.","volume":"273","author":"Spulber","year":"2013","journal-title":"J. Intern. Med."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113320","article-title":"Alzheimer\u2019s disease and its treatment by different approaches: a review.","volume":"216","author":"Srivastava","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"B45","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1474-4422(21)00361-6","article-title":"Blood-based biomarkers for Alzheimer\u2019s disease: towards clinical implementation.","volume":"21","author":"Teunissen","year":"2022","journal-title":"Lancet Neurol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1212\/WNL.0b013e3181af79fb","article-title":"MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change.","volume":"73","author":"Vemuri","year":"2009","journal-title":"Neurology"},{"key":"B47","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1093\/brain\/awr277","article-title":"Alzheimer\u2019s disease pattern of brain atrophy predicts cognitive decline in Parkinson\u2019s disease.","volume":"135","author":"Weintraub","year":"2012","journal-title":"Brain"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-020-00757-5","article-title":"An MRI-based strategy for differentiation of frontotemporal dementia and Alzheimer\u2019s disease.","volume":"13","author":"Yu","year":"2021","journal-title":"Alzheimers Res. Ther."},{"key":"B49","doi-asserted-by":"publisher","first-page":"6217","DOI":"10.18632\/aging.102184","article-title":"Risk estimation before progression to mild cognitive impairment and Alzheimer\u2019s disease: an AD resemblance atrophy index.","volume":"11","author":"Zhao","year":"2019","journal-title":"Aging"}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2022.932125\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T13:49:25Z","timestamp":1660830565000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2022.932125\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,5]]},"references-count":49,"alternative-id":["10.3389\/fnagi.2022.932125"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2022.932125","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,5]]},"article-number":"932125"}}